Inflammation a potential target for therapeutic intervention in heart failure.
Orrego
Carlos M
CM
Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.
D000818:Animals; D006333:Heart Failure / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007163:Immunosorbent Techniques; D007167:Immunotherapy / Q000379:methods; D007249:Inflammation / Q000276:immunology / Q000628:therapy*; D018836:Inflammation Mediators / Q000378:metabolism*; D010956:Plasmapheresis; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous; D018836:Inflammation Mediators